Leading-Edge Science: Merck and Ridgeback Provide Update

VIP LIVEALERTS-PRO Leading-Edge Science News Leading-Edge Science: Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO™ (Molnupiravir) RAHWAY, N.J. & MIAMI–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines […]
Sera Prognostics Announces Positive Top-line Data

VIP LIVEALERTS-PRO Sera Prognostics Positive Data Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital length-of-stay SALT LAKE CITY, Feb. 15, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker […]